Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology

Baseline levels of dynamic CD4+ T cell adhesion to MAdCAM-1 correlate with clinical response to vedolizumab treatment in ulcerative colitis: a cohort study (2020) Allner C, Melde M, Becker E, Fuchs F, Mühl L, Klenske E, Müller L, et al. Journal article Dietary lipids fuel GPX4-restricted enteritis resembling Crohn's disease (2020) Mayr L, Grabherr F, Schwrzler J, Reitmeier I, Sommer F, Gehmacher T, Niederreiter L, et al. Journal article Functional molecular network analysis enables prediction of response to vedolizumab therapy in anti-TNF refractory IBD patients (2020) Breidert M, Eftekhari P, Louis F, Rotoiu C, Rath T, Neurath M, Atreya R Journal article Successful Therapy of Crohn's Disease-Associated Pulmonary Necrobiotic Nodules on Ustekinumab Therapy (2020) Ganzleben I, Hirschmann S, Köhler J, Fuchs F, Rieker R, Baer E, Klenske E, et al. Journal article Swept source cross-polarized optical coherence tomography for any input polarized light (2020) Sharma G, Sharma S, Blessing K, Hartl G, Waldner M, Singh K Journal article The TLR9 agonist cobitolimod induces IL10 producing wound healing macrophages and regulatory T cells in ulcerative colitis (2020) Schmitt H, Ulmschneider J, Billmeier U, Scarozza P, Sonnewald S, Reid S, Atreya I, et al. Journal article, Original article CLARINET FORTE Baseline Characteristics: Lanreotide Autogel 120 mg (LAN) Every 14 Days in Patients With Progressive Pancreatic or Midgut Neuroendocrine Tumors During a Standard First-Line LAN Regimen (2020) Ruszniewski P, Cwikla J, Lombard-Bohas C, Borbath I, Shah T, Pape UF, Xuan-Mai Truong Thanh , et al. Conference contribution Investigating Intestinal Barrier Breakdown in Living Organoids (2020) Bardenbacher M, Ruder B, Britzen-Laurent N, Naschberger E, Becker C, Palmisano R, Stürzl M, Tripal P Journal article, Original article Quality of Life, Tumour Heterogeneity and Biomarker Levels in Patients with Progressive Pancreatic or Midgut Neuroendocrine Tumours: Baseline Data from CLARINET FORTE (2020) Ruszniewski P, Cwikla J, Lombard-Bohas C, Borbath , Shah T, Pape UF, Truong Thanh XM, et al. Conference contribution Prognosis and Management of Advanced Digestive Well-Differentiated Grade 3 Neuroendocrine Tumors (G3 NETs): A NET-CONNECT Study Performed in Four Expert Centers (2020) De Mestier L, Lamarca A, Hernando-Cubero J, Alonso Gordoa T, Cros J, Chakrabarty B, Landolfi S, et al. Conference contribution